{"id":12093,"date":"2017-04-21T07:13:23","date_gmt":"2017-04-21T07:13:23","guid":{"rendered":"http:\/\/revoscience.com\/en\/?p=12093"},"modified":"2017-04-21T07:13:23","modified_gmt":"2017-04-21T07:13:23","slug":"marriage-made-heaven-digital-inhaler-add-offers-slick-aid-asthma-care","status":"publish","type":"post","link":"https:\/\/www.revoscience.com\/en\/marriage-made-heaven-digital-inhaler-add-offers-slick-aid-asthma-care\/","title":{"rendered":"Marriage made in heaven: Digital inhaler add-on offers slick aid to asthma care"},"content":{"rendered":"<figure id=\"attachment_12094\" aria-describedby=\"caption-attachment-12094\" style=\"width: 629px\" class=\"wp-caption alignnone\"><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-12094\" src=\"http:\/\/revoscience.com\/en\/wp-content\/uploads\/2017\/04\/image002-500x500.jpg\" alt=\"\" width=\"629\" height=\"629\" title=\"\" srcset=\"https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2017\/04\/image002-500x500.jpg 500w, https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2017\/04\/image002-500x500-150x150.jpg 150w, https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2017\/04\/image002-500x500-300x300.jpg 300w\" sizes=\"auto, (max-width: 629px) 100vw, 629px\" \/><figcaption id=\"caption-attachment-12094\" class=\"wp-caption-text\">Propeller Health\u2019s device attaches to an inhaler and connects wirelessly to a smartphone, helping users and doctors understand what the use of rescue medicine says about asthma triggers. PROPELLER HEALTH, LLC<\/figcaption><\/figure>\n<p style=\"text-align: justify;\"><span style=\"color: #000000;\">What do you get by marrying an asthma inhaler to a wireless monitor and a smartphone app? Plenty, says David Van\u00a0Sickle, a medical anthropologist who specializes in respiratory disease.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #000000;\">In 2011, Van\u00a0Sickle created a spinoff called Propeller Health while he was working on respiratory disease prevention at UW Health in Madison.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #000000;\">Van Sickle arrived at UW\u2013Madison in 2006 with a grant to pursue what he calls \u201chigh-risk, high-reward technologies to better understand how we could monitor and intervene to help people and communities better manage the burden of asthma and COPD,\u201d (chronic obstructive pulmonary disease, or emphysema).<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #000000;\">In the United States, he adds, the direct and indirect costs of asthma are estimated at $56 billion.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #000000;\">Both asthma and COPD \u201care characterized by a persistent gap in what we should be able to achieve and what we have accomplished,\u201d Van\u00a0Sickle says. \u201cWe have a lot of effective therapies that are not being used, either at all, or to best effect.\u201d<\/span><\/p>\n<figure id=\"attachment_12095\" aria-describedby=\"caption-attachment-12095\" style=\"width: 168px\" class=\"wp-caption alignright\"><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-12095\" src=\"http:\/\/revoscience.com\/en\/wp-content\/uploads\/2017\/04\/image003-280x500-168x300.png\" alt=\"\" width=\"168\" height=\"300\" title=\"\" srcset=\"https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2017\/04\/image003-280x500-168x300.png 168w, https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2017\/04\/image003-280x500.png 280w\" sizes=\"auto, (max-width: 168px) 100vw, 168px\" \/><figcaption id=\"caption-attachment-12095\" class=\"wp-caption-text\">By forecasting conditions that are likely to exacerbate asthma, the Propeller device can help patients take regular meds that reduce symptoms. PROPELLER HEALTH, LLC<\/figcaption><\/figure>\n<p style=\"text-align: justify;\"><span style=\"color: #000000;\">Propeller Health makes an add-on device for inhalers that communicates with a smartphone that records the use of routine preventative medicines and \u201crescue\u201d medications intended to open constricted airways. This gives the patient useful information on their smartphone or website about whether routine meds are being taken as scheduled, and it shows them patterns that trigger the need for rescue medicines.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #000000;\">\u201cOver time, we learn when and where you need your rescue inhaler, and so we\u2019re able to teach people something they may not understand: \u2018When you are wheezing, it\u2019s often high humidity and you are at work.\u2019 With this information, you can take steps to avoid those exposures.\u201d<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #000000;\">To date, Propeller has raised $45.5 million in investment funding. It has 65 full-time employees, including about 40 in Madison and the rest in San Francisco. About one-quarter of the employees are UW\u2013Madison alumni, largely from the Department of Computer Sciences and the Wisconsin School of Business. About 10,000 people are using the system in the United States, says Van\u00a0Sickle, and the company is expanding into Canada and Europe.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #000000;\">Generally, the <a style=\"color: #000000;\" href=\"https:\/\/www.propellerhealth.com\/\" target=\"_blank\" rel=\"noopener\">Propeller Health<\/a> system is purchased by health plans or provider systems, which make it available to patients, often through a primary care doctor. \u201cGenerally, these organizations are at economic risk for the patient outcome,\u201d Van\u00a0Sickle says. \u201cIf you are a health insurance company, you are frustrated at having to pay for asthma attacks and emergency room visits that are preventable with current therapy.\u201d<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #000000;\">Ironically, Propeller is succeeding by doing something that can be forgotten in the rush to create better treatments. The company is \u201cnot trying to invent radical new therapies, but to make better use of the tools that we already know will work to help get the condition under control,\u201d Van\u00a0Sickle says, \u201cso people are less impaired and have less risk of flare-ups because they are managing the underlying disease and thus preventing symptoms. By reminding and encouraging people to use the daily therapies, our research shows that this has a big impact on driving down the frequency of exacerbations and use of rescue medicines.\u201d<\/span><\/p>\n<figure id=\"attachment_12096\" aria-describedby=\"caption-attachment-12096\" style=\"width: 169px\" class=\"wp-caption alignright\"><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-12096\" src=\"http:\/\/revoscience.com\/en\/wp-content\/uploads\/2017\/04\/image007-281x500-169x300.png\" alt=\"\" width=\"169\" height=\"300\" title=\"\" srcset=\"https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2017\/04\/image007-281x500-169x300.png 169w, https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2017\/04\/image007-281x500.png 281w\" sizes=\"auto, (max-width: 169px) 100vw, 169px\" \/><figcaption id=\"caption-attachment-12096\" class=\"wp-caption-text\">A little advice can go a long way toward reducing the severity of asthma.<\/figcaption><\/figure>\n<p style=\"text-align: justify;\"><span style=\"color: #000000;\">Propeller has two other related roles. Van Sickle, who trained as a medical anthropologist, came to UW\u2013Madison from the Centers for Disease Control and Prevention, where he specialized in the epidemiology of disease. With its ability to monitor the use of both daily preventive and rescue medications, Propeller \u201ccan contribute information to clinical trials of all shapes and sizes,\u201d he says.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #000000;\">A summary screen shows all of a particular physician\u2019s patients at once, \u201cso you can quickly identify patients who would benefit from a phone call, an adjustment to medication or an exam,\u201d Van\u00a0Sickle says.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #000000;\">The same system can be used to monitor COPD, helping patients avoid situations \u2014 like polluted air \u2014 that further impair their lung function, Van\u00a0Sickle says. \u201cCOPD is heading toward being a leading killer around the world; it\u2019s one of the few conditions where the trend is going in the wrong direction.\u201d<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #000000;\">Even amid ongoing uncertainty about the future of health insurance, Van\u00a0Sickle sees a role for a system that optimizes the use of resources. \u201cFrom our perspective, regardless of what happens with health care, as long as we can deliver better outcomes and lower costs, we have a compelling business model.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #000000;\">\u201cAsthma causes about 4,000 deaths per year in the United States, and the consensus is that virtually every one is preventable with appropriate treatment,\u201d Van\u00a0Sickle says. \u201cYet there are hundreds of thousands of hospitalizations, and millions of ER visits. These are treatment failures that should never occur.\u201d<\/span><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>What do you get by marrying an asthma inhaler to a wireless monitor and a smartphone app? Plenty, says David Van\u00a0Sickle, a medical anthropologist who specializes in respiratory disease. In 2011, Van\u00a0Sickle created a spinoff called Propeller Health while he was working on respiratory disease prevention at UW Health in Madison. Van Sickle arrived at [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":12094,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26,22],"tags":[],"class_list":["post-12093","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicine","category-other"],"featured_image_urls":{"full":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2017\/04\/image002-500x500.jpg",500,500,false],"thumbnail":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2017\/04\/image002-500x500-150x150.jpg",150,150,true],"medium":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2017\/04\/image002-500x500-300x300.jpg",300,300,true],"medium_large":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2017\/04\/image002-500x500.jpg",500,500,false],"large":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2017\/04\/image002-500x500.jpg",500,500,false],"1536x1536":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2017\/04\/image002-500x500.jpg",500,500,false],"2048x2048":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2017\/04\/image002-500x500.jpg",500,500,false],"ultp_layout_landscape_large":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2017\/04\/image002-500x500.jpg",500,500,false],"ultp_layout_landscape":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2017\/04\/image002-500x500.jpg",500,500,false],"ultp_layout_portrait":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2017\/04\/image002-500x500.jpg",500,500,false],"ultp_layout_square":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2017\/04\/image002-500x500.jpg",500,500,false],"newspaper-x-single-post":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2017\/04\/image002-500x500.jpg",490,490,false],"newspaper-x-recent-post-big":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2017\/04\/image002-500x500.jpg",360,360,false],"newspaper-x-recent-post-list-image":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2017\/04\/image002-500x500.jpg",65,65,false],"web-stories-poster-portrait":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2017\/04\/image002-500x500.jpg",500,500,false],"web-stories-publisher-logo":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2017\/04\/image002-500x500.jpg",96,96,false],"web-stories-thumbnail":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2017\/04\/image002-500x500.jpg",150,150,false]},"author_info":{"info":["Amrita Tuladhar"]},"category_info":"<a href=\"https:\/\/www.revoscience.com\/en\/category\/health\/medicine\/\" rel=\"category tag\">Medicine<\/a> <a href=\"https:\/\/www.revoscience.com\/en\/category\/news\/other\/\" rel=\"category tag\">Other<\/a>","tag_info":"Other","comment_count":"0","_links":{"self":[{"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/posts\/12093","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/comments?post=12093"}],"version-history":[{"count":0,"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/posts\/12093\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/media\/12094"}],"wp:attachment":[{"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/media?parent=12093"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/categories?post=12093"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/tags?post=12093"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}